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Biomarkers in the Detection of Human
Heritable and Germinal Mutagenesis
by Mortimer L. Mendelsohn*
An important potential use of biomarkers in human toxicology is the detection of induced mutational
events in offspring and germ cells ofexposed individuals. The importance, of course, is in risk estimation
and the identification and prevention of exposure conditions that are harmful to the human genome. The
challenge is to discover methods of sufficient power to find the rare, random, mutational events and to
discriminate such events from other sources of molecular variation. Finding mutations is essentially a
search for disorder. Normal biomarkers are inherently unsuitable in a positive search for disorder; instead
one must either use abnormal markers or be prepared to search negatively, i.e., to look for and somehow
validate the rare absence of a normal marker. In spite ofthese difficulties, there is progress to report and
hope of future success in this field.
Background
The major and most promising setting for observing
an induced mutation rate in a human population is
amongthe offspringofA-bomb survivors inJapan. Ion-
izing radiation is a consistent mutagen in all living or-
ganisms, and the human should be no exception. A size-
able body of data in the mouse indicates a mammalian
gametic doubling dose for specific locus mutations from
gamma radiation ofabout 40 rad. Thousands ofchildren
have been born to parents exposed to the A-bomb who
collectively have received on the order of 100 rad, cor-
responding to roughly a gametic doubling dose if mice
and humans have similar radiation sensitivity. Such
doses forindividuals have beenreasonably welldefined,
andthecarefulworkoftheAtomicBombCasualty Com-
mission (ABCC) and now the Radiation Effects Re-
search Foundation (RERF) has kept track of the indi-
viduals and their health effects (1).
Conventional methods to detect adversereproductive
orgenetichealthoutcomes intheA-bomboffspringhave
yielded no results. Pregnancy outcome, childhood mor-
tality, and sentinel phenotypes have been looked at to
varying degree without any indication of a dose-re-
sponse function or a significant difference between ex-
posed and controls. (Note that this does not apply to
the effects ofinutero exposure where clear cut and low-
dose effects have been observed.) An extensive search
for induced heritable chromosome aberrations has also
been negative.
Over the past 14 years, a major effort to find muta-
tional change in gene products has been carried out by
the RERF staff under the inspiration of James Neel
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(1). The RERF methodusesgelelectrophoresis toiden-
tify a charge change in enzymes that retain sufficient
enzymological function to be identifiable on the gels.
Some 30 enzymes in the red blood cells oftens ofthou-
sands of children of A-bomb survivors have been ex-
amined. When an unusual pattern is found in a child,
the parents are tested both for the absence ofthe var-
iant and for biological paternity. A mutation is scored
when all three results are positive. As summarized in
Table 1, only six mutations have been found in more
than 1 million loci tested (2). These mutations divide
equally into the exposed and control populations, indi-
catingabackground electromorphicmutationrate of0.5
X i0-5 and no observable effect on mutation rate from
the 100 rad exposure.
It is instructive to relate these results back to the
mouse. The average gonadal dose these children's par-
ents received is approximately the same as the mouse
doubling dose, and hence by direct analogy one might
have expected something like six mutations in the ex-
posed group and three in the control group, ratherthan
three mutations in each group. The absence ofthe dou-
Table 1. One-dimensional electrophoresis of children ofA-bomb
survivors, 1972-1986.a
Proximally exposed Distally exposed
parents parents
Dose, T65
Gamma, rad 74.8 < 1
Neutron, rad 10.9
Loci tested 725,587 539,170
Mutations 3 3
Mutation rate per locus
per generation 0.4 x 10-5 0.5 x 10-i
aFrom Satoh et al. (2).M. L. MENDELSOHN
bling effect raises several possibilities: statistical fluc-
tuation is secondary to the smallness of the numbers,
thehumanismoreresistanttomutationthanthemouse,
or something is wrong with the experiment. Perhaps
the best explanation is the difference in the two end
points being detected, i.e., the loss of function of one
of seven recessive genes in the mouse versus a charge
change in the presence of residual enzyme function in
the human. The human end point is a relatively less
likely outcome ofionizing radiation, and when the very
approximate dataonfrequencies oftypesofbackground
and radiation-induced DNA damage are factored into
the human data, the results suggest an expected in-
crease of electromorphs of something like 30% rather
than 100% (3). This places the expectation inthe human
at four and three mutations in the exposed and control
groups, respectively, instead ofthree mutations in each
group. To detect an outcome of this magnitude at the
5% level ofsignificance with a power of 90% would re-
quire the harvesting of over 500 mutations. According
to this line of reasoning, the data fall close to expec-
tation, but are 100 times too small.
Two important points about the demands on any mu-
tation-detecting method should be made. First, the
events are exceedingly rare, even for this dramatically
exposed population; and second, one must have a very
clear understanding ofthe types ofevents that are ex-
pectedandthatcanbedetectedbyone'smethodinorder
to anticipate the yield and to relate the results to other
data sets or to risk.
The Potential for New Methods for
Heritable Mutation
There are two classes of new methods for detecting
heritable mutation: those involving gene products and
those involving DNA. The one entry in the first class
is a direct extension ofone-dimensional electrophoresis
to the second dimension (4-6). Intwo-dimensional elec-
trophoresis, gene products (proteins) are characterized
by charge and by mass. There is a gain ofboth physical
information about the protein and number of protein
types seen, but a loss of functional information about
the proteins. Hundreds of spots may be seen in a two-
dimensional gel, but few of the spots are collated to
known molecules orto underlyingfunction. In addition,
it is difficult in current gels to estimate the amount of
material in many spots on the same gel, and thus to
know when half of a spot is missing, signaling the pos-
sibility that one of the two alleles is no longer repre-
sented in that spot. Although the matter is controver-
sial, there is a serious question as to whether this
method will provide the power necessary to become an
effective screening test for heritable mutation.
The other class of methods involves DNA, or more
specifically, deviations ofthe child's DNA from that of
its parerits (3). The dramatic explosion of DNA tech-
nology in the past decade has resulted in remarkable
power to manipulate and analyze the genetic material.
Four examples ofhow this might be used for mutation
testing will be discussed briefly.
The best known and most widely used method is re-
striction-fragment-length-polymorphism (RFLP). Fig-
ure 1 illustrates how the combination of a restriction
enzyme and a DNA probe define a DNA fragment of
specific length. When either ofthebounding restriction
sites is eliminated by a mutational change in the DNA,
there is a clear alteration in the fragment length. In
fact, each combination of six-cutter restriction enzyme
and DNA probe tests, in a haploid genome, for the
integrity of 18 basepairs, 12 by potential loss of site,
and 6 by potential gain of site. Similar effects can also
beproduced by DNArearrangements which changethe
distance between bounding sites. The technology to
demonstrate such effects is in wide use today, but its
application to mutation testing is severely inhibited by
several factors. The background rate for heritable base
changes in the human genome is estimated to be 10-8.
Thus, it would be necessary to examine on the average
108 basepairs to find one background mutation. As an
example, this number of basepairs could be tested by
using10restrictionenzymes, 278probes, andthediploid
genomes of 1,000 children. Since a typical DNA gel can
hold about 30 lanes (from 10 parent-child triads) and
can be used for 20 probes, such an RFLP, examines
7200 basepairs. The measurement of 108 basepairs re-
quires 14,000 gels and costs approximately $1.4 million
per single background event. Given these logistics,
RFLP is not a practical candidate for mutation testing
of base substitutions at this time, but it does serve as
an abstract benchmark for comparing other methods.
The second DNA method to be considered is DNA
sequencing. In a sense, sequencing is the ultimate
method to analyze mutations, since the complete se-
quences of the triad of involved genomes contains all
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FIGURE 1. Restriction fragment length polymorphism applied to
mutation detection. Parental and child's DNA are compared for
probe site and six-cutter restriction site. In the child, the base
change points to substitution of one of the six bases ofthe prior
cutting site. This change neutralizes the site and results in the
expansion of the DNA fragment to the next site. The difference
in size is detectable in a Southern blot taken from a sizing gel.
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the information to count and characterize mutational
change. Perhaps some day such an approach can be
considered, but to put this issue in perspective, one has
onlyto observe the currentcontroversy overtheimpact
on biological science ofsequencingjust one human gen-
ome, let alone hundreds.
The third method takes advantage of the ability of
RNAse A to cleave mismatches in RNA:DNA hetero-
duplexes (7). Probes of complementary, radiolabeled
RNA are prepared from representative parts of a ref-
erence genome and are allowed to hybridize to conven-
iently sized pieces of genomic DNA from parents and
child. Treatment with RNAse will cut the RNA at sites
ofmismatch and give a characteristic pattern when the
RNA is run out on a sizing gel. Comparison ofthe pat-
terns within the triad should indicate base changes and
small rearrangements unique to the child. The method
detects more that 50% ofsingle base changes, and has
an estimated efficiency that is more than 10 times
greater than RFLP. Even with this improvement, the
cost and effort make this very difficult as a practical
application. At least three laboratories are exploring
the future possibilities of the method.
The fourth DNA method to be considered is the least
wellunderstood fromapracticalviewpoint, butisworth
considering here because of its exciting potential for
enormous increases in efficiency. It is called subtractive
hybridization and was introduced several years ago by
George Church (3). It is based on the dramatic effect
on melting temperature of a single base mismatch be-
tween an 18-mer of DNA and a fragment of genomic
DNA in a solvent that minimizes adenine-thymine-
guanine-cytosine differences in melting. To take advan-
tage of this, Church visualizes a library of all possible
18-mers of DNA. The genomic DNA ofboth parents is
combined, fragmented to 50 to 200 basepairs in size,
mixed in large excess with an aliquot of the 18-mer
library, and heated in tetramethyl ammonium chloride
tojust below the melting temperature. After sufficient
time to maximize hybridization ofperfect matches, the
unmatched 18-mers are separated and mixed under the
same conditions with the child's DNA. Since these 18-
mers represent sequences that are not found in either
parent, the presence ofperfect matches with the child
will signify mutations. In the final stage, such matches
can be separated and analyzed by a variety ofmethods
to count the events, find the involved genes, or specify
the precise mutational changes. Since with the excep-
tion ofthe last stage, the analysis ofthe entire genome
is done in parallel by Church's method, the relative
efficiency can be enormous. The question is whether or
not the thermodynamics of hybridization and the sub-
sequent separations will permit the necessary discrim-
ination to make the method work.
Of these four DNA methods, the RNAse cleavage
approach is the only one that comes close to practical
applicationatpresent. Thehopeisthatfurtheradvances
will be made, suggesting other parallel or otherwise
highly efficient methods, and that the Church method
will be properly evaluated.
AfifthtypeofDNAmethod istheapplication ofDNA
hybridization to cytogenetics. Chromosome paintingby
hybridization was first shown inhuman-hamsterhybrid
cells in which the human chromosomes were brilliantly
stained using fluorescently labeled human genomic
DNA (8). Translocations of the painted chromosomes
are easy to recognize, and scoring them is orders of
magnitude faster than conventional methods. Painting
specific human chromosomes in human cells is under
development and relies on the selection ofbatteries of
uniquesequenceDNAprobesfromchromosome-specific
gene libraries. Human chromosome 21 can already be
partially painted with this method (9). An exciting var-
iant of this method has the potential to extend cyto-
genetics into the microchromosomal region by combin-
ing the painting with developing methods of DNA
manipulation. The manipulation is by orthogonal field
alternating gradient electrophoresis (OFAGE), which
for the first time permits resolution of large, million
basepair or more DNA molecules (10,11). Cantor and
colleagues have already demonstrated that an eight-
cutterdigest ofhumanchromosome21 produces aclear,
reproducible series ofbands in OFAGE (personal com-
munication). The microcytogenetic potential of these
two methods can be understood by imagining an eight-
cutter digest of human genomic DNA. When run by
OFAGE, such DNA will show a collage ofoverlapping
bands coming from each of the 24 human chromosome
types. By painting this preparation with DNA probes
designed for chromosome 21, only the bands from chro-
mosome 21 should light up,, thus providing both the
chromosome specificity and the subchromosomal reso-
lution. This microcytogenetic display is two orders of
magnitude below current methods and should have the
powertoseearepresentative sampleofrearrangements
in the size range between chromosomes and cosmids
currently a kind ofno-man's land ofgenetic resolution.
Potential Methods for Germinal
Mutation
As has already been pointed out, the rarity of her-
itable mutation greatly complicates the measurement
of altered mutation rate in small numbers of exposed
people. However, as with somatic mutation methods,
the limited number of subjects can be sidestepped by
focusing attention on sperm where samples ofmillions
ofcells are obtainable from a single male. The problem
then becomes how to identify mutations when dealing
withsinglecells. Atthemoment, suitableDNAmethods
at this level of resolution are not available, but there
are good precedents for identifying mutated cells from
their gene products.
Of these precedents, the prototype that may be ex-
tendable togerminal cells is the somaticmutation assay
using glycophorin A (12,13). This sialoglycoprotein is
the most abundantmacromolecule inthe humanred cell
membraneandisresponsible fortheMandNserotypes.
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Halfofthe population is heterozygous MN, and in such
people, the two alleles are codominant, putting 250,000
copies of each protein into every red cell membrane.
The M and N forms differ by only two amino acids in
the external, terminal region of the molecule. Mono-
clonal antibodies havebeengeneratedtomarkeachpro-
tein with high affinity and specificity. Using flow cy-
tometry, one million red cells canbe screened in 15min,
identifying and sorting all cells that have a normal
amount of one allelic product and none of the other.
These presumptive gene loss mutants occur at the rate
of 10 per million red cells in normal heterozygotes, ap-
pear to increase linearly as a function ofradiation dose
in A-bomb survivors (14), and also respond to a variety
of mutagenic cancer chemotherapies.
To conduct a comparable test with sperm requires
similar markers that are controlled independently by
two alleles or two related genes. In work in progress
atthis laboratory, Wyrobek and colleagues have chosen
the two human protamines as a likely target. These
molecules are exclusive to sperm, are expressed in the
haploidstate, andaretightlyintegratedintothenucleus
with minimal chance for intercellular interaction. Mon-
oclonalantibodies havebeenpreparedtodistinguish the
two protamines (15), and very early pilot flow-cyto-
metric experiments have shown control measurements
and results comparable to glycophorin A. It is too early
to claim this as a successful mutation method, but the
principle is clear and should be applicable to other mol-
ecules.
The generalrequirements for such biomarkers ofmu-
tation fall into two categories. Forpositive biomarkers,
one starts with a known mutant gene product, develops
amethod to identify it in single cells, and then searches
directly for the mutant cells. An example of this ap-
proach using antibody detection is the search for sickle
red cells in people who have not inherited a sickle gene
(16). We have prepared good monoclonal antibodies for
detection of sickle hemoglobin at the single cell level
(17), and have learned how to apply them to red cells
in suspension. Since the hemoglobin mutants represent
a specific change of a specific base, they are expected
to occur at two-orders of magnitude lower frequency
than loss ofgene product. Thus, itis not surprisingthat
the sickle cells have apparently been found at rates
approximating one per 10 million cells in normal blood.
We have been unable to measure events of this rarity
with sufficient reliability to mount a practical method.
Inaddition, ourexperience withglycophorin Asuggests
another limitation based on the finite number oferyth-
rocyticstemcellsavailabletoexpressthemutationrate.
Our current data indicate that there are enough stem
cells to carry the 10 in a million rate for gene loss, but
at doses of several hundred rad, the measurements of
mutant cells become discontinuous and must be aver-
aged across subjects to be useful. We lack the data to
be certain, but the hemoglobin system should be essen-
tiallynonresponsive inthesingle subjectbecause ofthis
limitation. It is likely that the same will be true for
almost any system using a positive biomarker.
For negative biomarkers, the strategy is to find de-
tection methods for normal gene products. In this case
the problem is to control for the metabolic, physiologic,
and other toxicologic reasons for nonexpression or non-
measurement of the gene product. In the case of gly-
cophorin A this is done by having the two codominant
alleles separately labeled and insisting that one express
normally. In the case of protamine, the approach is to
usetwogeneswithalmostidenticalfunction, inthehope
thatwhathappens to one (otherthanmutation) happens
to the other. For glycophorin A we are dealing with
enucleate red cells and have no direct way as yet to
confirmthemutationalnatureofwhatisbeingobserved.
In the case ofthe protamines there is the possibility to
collect the mutant cells and use their DNA to try to
confirm what has happened. In both cases the approx-
imate frequency of expected events is known, and one
can use the classical response to mutagens to add con-
fidence that it is indeed mutations that are being meas-
ured.
Overview
It should be clear by now why this type of use of
biomarkers is demanding and exceptional. It is hoped
that within a few years it will also be clear that the
approach is successful in this very important aspect of
reproductive toxicology-the estimation of heritable
and germinal mutation in human populations.
Work performed under the auspices of the U.S. Department of
Energy by the Lawrence Livermore National Laboratory under con-
tract number W-7405-ENG-48.
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